Novartis

ADAKVEO - Cost

Last Updated: April 1st, 2024

HCPCS:

J0791

HCPCS Code Descriptor:

Injection, crizanlizumab-tmca, 5 mg

Medicare Payment Limit:

The ADAKVEO Medicare Payment Limit is $127.351

Average Sale Price:

ADAKVEO ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The ADAKVEO Medicare Co-insurance percentage is 20%. ADAKVEO's Medicare Co-insurance amount is $25.47 per HCPCS unit.

APC Code:

The Adakveo APC Code is: 9359

APC Payment Limit:

The APC Payment Limit for ADAKVEO is available. Login to view.

Adakveo Cost Information:

Adakveo's HCPCS J0791. It was added and became effective on July 1, 2020. Since July 2022, the AWP has remained at a fairly consistent level. There have been slight price increases each year in January of less than 1%. The WAC has followed a similar trend, with very slight price increases each year in January, each amounting to less than $1 increase in price. The ASP has remained close to the WAC, following it's trends and gradually rising in price over time.

ACCESS PRICING AND MORE BY REGISTERING

Adakveo’s wholesale acquisition cost (WAC) information was last updated on:
January 4, 2023
Adakveo’s average wholesale price (AWP) information was last updated on:
January 4, 2023